Barclays analyst Benjamin Budish raised the firm’s price target on Carlyle to $46 from $38 and keeps an Overweight rating on the shares. The analyst says a “soft landing” and falling rates are somewhat mixed for the brokers and asset management sector. This bodes well for the alternative asset managers despite the recent run in shares, the analyst tells investors in a research note. The firm also realigned its exchange ratings heading into 2024.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CG:
- Carlyle initiated with a Market Perform at TD Cowen
- Carlyle, Insight Partners to invest in Exiger
- Carlyle, Insight acquire Exiger in deal valuing company at $1.2B, WSJ says
- Carlyle’s Rubenstein in negotiations to buy Baltimore Orioles, Bloomberg reports
- Carlyle to replace ICU Medical in S&P 400 at open on 11/30
